RVP

Retractable

--(--)

Market Open: --

--(--)

Post-Market: --

Key Stats

--DAY`S RANGE--

--52 WK RANGE--

Open

Prev.Close

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

Low

52 Week High

52 Week Low

About RVP

Retractable Technologies, Inc.

A company that develops patented safety needle devices and other safety medical products for the healthcare industry

Industry

Healthcare Equipment and Supplies

Established Date

05/09/1994

Listing Date

05/04/2001

Exchange

American Stock Exchange

Full-time Employees

227

Fiscal Year Ends

12-31

Website

www.retractable.com

Security Type

Common stock

Office address

511 Lobo Lane , Little Elm , Texas 75068-5295

Business

Introduction

Retractable Technologies, Inc., incorporated in Texas on May 9, 1994, is responsible for the design, development, manufacture and sale of safe syringes and safe medical products for the healthcare industry. The company began developing its manufacturing operations in 1995. The company's manufacturing and administrative facilities are located in Little Elm, Texas. The main products notified by the company and the FDA are Vanish Point 0.5 mL insulin syringe; 1 mL tuberculin, insulin, allergy antigen syringe; 0.5 mL, 2 mL, 3 mL, 5 mL, 10 mL syringe; small caliber tube adapter; blood collection tube frame; allergy tray; intravenous catheter safety; patient safety syringe; patient safety LUer cap.

Company Financials

EPS

RVP has released its 2023 Q3 earnings. EPS was reported at -0.14, versus the expected 0.00, missing expectations. The chart below visualizes how RVP has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

RVP has released its 2024 Q4 earnings report, with revenue of 9.07M, reflecting a YoY change of -36.50%, and net profit of 3.77M, showing a YoY change of 5269.20%. The Sankey diagram below clearly presents RVP’s revenue sources and cost distribution.